JEFFREY ROGER GRANETT
Medical Practice in Delaware

License number
Pennsylvania MD038305E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address 2
Delaware
Rosemont, PA 19010

Personal information

See more information about JEFFREY ROGER GRANETT at radaris.com
Name
Address
Phone
Jeffrey Granett, age 81
411 Boxwood Rd, Bryn Mawr, PA 19010
Jeffrey R Granett, age 81
411 Boxwood Rd, Bryn Mawr, PA 19010
(610) 525-4977

Professional information

Jeffrey Granett Photo 1

Composition Comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl] Thiazolidine-2,4-Dione

US Patent:
2004008, Apr 29, 2004
Filed:
Nov 19, 2003
Appl. No.:
10/716923
Inventors:
Jeffrey Granett - Rosemont PA, US
Hamish Ross - Berwyn PA, US
Jaikrishna Patel - Research Triangle Park NC, US
Robin Price - Great Dunmow, GB
Paul Wray - Crawley, GB
International Classification:
A61K031/4439
US Classification:
514/342000
Abstract:
A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.


Jeffrey Granett Photo 2

Composition Comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dione

US Patent:
2004018, Sep 16, 2004
Filed:
Mar 24, 2004
Appl. No.:
10/808014
Inventors:
Jeffrey Granett - Rosemont PA, US
Hamish Ross - Berwyn PA, US
Jaikrishna Patel - King of Prussia PA, US
Robin Price - Great Dunmow, GB
Paul Wray - Crawley, GB
International Classification:
A61K031/4439
US Classification:
514/342000
Abstract:
A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.


Jeffrey Granett Photo 3

Composition Comprising 5-[4-[2-(N-Methyl-N-2-Pyridy)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dione

US Patent:
2002017, Nov 28, 2002
Filed:
Feb 5, 2002
Appl. No.:
10/068514
Inventors:
Jeffrey Granett - Rosemont PA, US
Hamish Ross - Berwyn PA, US
Jaikrishna Patel - , US
Robin Price - Great Dunmow, GB
Paul Wray - Crawley, GB
Assignee:
SmithKline Beecham p.I.c.
International Classification:
A61K031/4439
US Classification:
514/340000
Abstract:
A pharmaceutical composition comprising Compound (1), characterised in that the composition comprises 2 to 12 mg of Compound (1) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.


Jeffrey Granett Photo 4

Composition Comprising 5-[4-[2-(N-Methyl-N-2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dione

US Patent:
2003018, Oct 2, 2003
Filed:
Mar 21, 2003
Appl. No.:
10/394858
Inventors:
Jeffrey Granett - Rosemont PA, US
Hamish Ross - Berwyn PA, US
Jaikrishna Patel - Research Triangle Park NC, US
Robin Price - Great Dunmow, GB
Paul Wray - Crawley, GB
International Classification:
A61K031/4439
US Classification:
514/342000
Abstract:
A pharmaceutical composition comprising Compound (I), characterised in that the composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such a composition in medicine, processes for the preparation of such a composition and intermediate composition useful in such a process.